These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 20024841

  • 1. Ion Channels as Therapeutic Targets--CHI's Fourth Annual Conference.
    Thorneloe KS.
    IDrugs; 2010 Jan; 13(1):16-9. PubMed ID: 20024841
    [Abstract] [Full Text] [Related]

  • 2. RNAi for Developing Targeted Therapeutics--CHI's Third Annual Meeting.
    Plane G.
    IDrugs; 2010 Jan; 13(1):20-2. PubMed ID: 20024842
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Therapeutic scope of modulation of non-voltage-gated cation channels.
    Li S, Gosling M, Poll CT, Westwick J, Cox B.
    Drug Discov Today; 2005 Jan 15; 10(2):129-37. PubMed ID: 15718162
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. HDAC Inhibitors--CHI's Third Annual Conference.
    Rosato RR.
    IDrugs; 2010 Jan 15; 13(1):13-5. PubMed ID: 20024840
    [Abstract] [Full Text] [Related]

  • 8. Ion channel modulators: new targets and new indications for old targets.
    Priest B, Kaczorowski GJ, Garcia ML.
    Curr Opin Drug Discov Devel; 2006 Sep 15; 9(5):587-94. PubMed ID: 17002219
    [Abstract] [Full Text] [Related]

  • 9. Discovery on Target 2007--CHI's Fifth Annual Conference. Ion channels.
    Beeton C.
    IDrugs; 2007 Dec 15; 10(12):851-4. PubMed ID: 18041678
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Ion channels and epilepsy].
    Armijo JA, de las Cuevas I, Adín J.
    Rev Neurol; 2000 Jun 15; 30 Suppl 1():S25-41. PubMed ID: 10904966
    [Abstract] [Full Text] [Related]

  • 12. Ion channels in T lymphocytes: an update on facts, mechanisms and therapeutic targeting in autoimmune diseases.
    Varga Z, Hajdu P, Panyi G.
    Immunol Lett; 2010 May 04; 130(1-2):19-25. PubMed ID: 20026117
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic approaches to ion channel diseases.
    Camerino DC, Desaphy JF, Tricarico D, Pierno S, Liantonio A.
    Adv Genet; 2008 May 04; 64():81-145. PubMed ID: 19161833
    [Abstract] [Full Text] [Related]

  • 14. [Animal toxins and ion channels].
    Darbon H.
    J Soc Biol; 1999 May 04; 193(6):445-50. PubMed ID: 10783702
    [Abstract] [Full Text] [Related]

  • 15. Ion channels as potential targets for the treatment of depression.
    Lodge NJ, Li YW.
    Curr Opin Drug Discov Devel; 2008 Sep 04; 11(5):633-41. PubMed ID: 18729015
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine.
    Nilius B, Szallasi A.
    Pharmacol Rev; 2014 Jul 04; 66(3):676-814. PubMed ID: 24951385
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical trials in CNS--SMi's eighth annual conference.
    Kirk R.
    IDrugs; 2010 Feb 04; 13(2):66-9. PubMed ID: 20127552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.